KK
NVAX icon

KLP Kapitalforvaltning’s Novavax NVAX Stock Holding History

KLP Kapitalforvaltning’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Hold
29,100
– – ﹤0.01% 1769
2026
Q1 		$237K Hold
29,100
– – ﹤0.01% 1758
2025
Q4 		$196K Hold
29,100
– – ﹤0.01% 1847
2025
Q3 		$252K Hold
29,100
– – ﹤0.01% 1722
2025
Q2 		$183K Hold
29,100
– – ﹤0.01% 1822
2025
Q1 		$187K Hold
29,100
– – ﹤0.01% 1775
2024
Q4 		$234K Buy
+29,100
New +$281K ﹤0.01% 1756

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

KLP Kapitalforvaltning's NVAX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Novavax (NVAX) position steady in Q2 2026 at 29,100 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

KLP Kapitalforvaltning first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • KLP Kapitalforvaltning held 29,100 shares of Novavax worth $274K as of Q2 2026.
  • KLP Kapitalforvaltning left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1769 holding.
  • KLP Kapitalforvaltning first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.